Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation/IPO

Uhuru to connect to UK's public markets
IoT management software provider Uhuru plans to file for an offering that would allow Salesforce, Mitsui, SoftBank, NEC and NGK Spark Plug to exit.
10x Genomics gees up for $100m IPO
SoftBank-backed medical research technology provider 10x Genomics, valued at nearly $1.3bn as of this year, has filed to go public.
IGM Biosciences eyes public markets spot
Anti-cancer antibody developer IGM has filed to raise up to $100m, weeks after securing $102m in a Haldor Tops√łe-backed series C round.
SpringWorks sparks $115m IPO filing
GlaxoSmithKline and Pfizer are in line for exits after oncology drug developer SpringWorks filed to float on the Nasdaq Global Market.
Satsuma sets course for public markets
Shin Nippon spinoff Satsuma has filed for an $86.3m initial public offering that will fund phase 3 trials of its migraine candidate.
TSE gives Giftee IPO permission
The digital gifting platform, which counts KDDI as its largest investor, expects to raise approximately $51.7m when it floats in Tokyo.
Cloudflare to cross over to public markets
The Alphabet, Baidu, Microsoft and Qualcomm-backed hosting services provider has filed to raise $100m in its IPO, five months after raising money at a reported $3.2bn valuation.

Other News

Chatwork talks its way to Tokyo IPO
Tokyo Stock Exchange has approved an initial public offering for enterprise communication platform Chatwork that will enable GMO Venture Partners to exit.
We Company releases billion-dollar IPO filing
SoftBank-backed workspace provider We Company has filed for an initial public offering in which it reportedly expects to raise up to $4bn.
Analysis: IPOs of corporate-backed businesses
2018 was a peak year in number of IPOs of corporate-backed emerging business, while the first half of 2019 saw some much-awaited IPOs like those of Uber, Lyft and Slack. In this short analysis, we look at the broader picture for corporate-backed companies going public.
Rapt retreats from IPO
Alphabet and Celgene are among the investors facing a delayed exit from Rapt Therapeutics, which has postponed an initial public offering that would have raised up to $80m.
9f lines up $150m IPO
SIG-backed online lending platform developer 9f has filed for a $150m initial public offering in the US that would also enable SBI to exit.
Livongo looks strong in $355m IPO
Livongo priced its shares above their range to raise more than $355m, providing exits to Merck GHI, M12, Humana, Zaffre Investments and Echo Health Ventures.

Editor's Picks

We Company releases billion-dollar IPO filing
SoftBank-backed workspace provider We Company has filed for an initial public offering in which it reportedly expects to raise up to $4bn.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Slack slides into public markets
The SoftBank, Comcast and Alphabet-backed communication platform developer saw its shares pop and its market cap climb nearly 50% to $19.5bn following its direct listing.
test reg

Login